Inventor · disambiguated record
Andrew Alistair Wylie
Also filed as: WYLIE ANDREW · WYLIE ANDREW A · WYLIE ANDREW ALISTAIR
5 granted patents·4 pending applications·15 citations·filing 2005–2024
71Inventor score
Top patents by PatentIndex Score
9 records- 0185US7851637B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersINFINITY PHARMACEUTICALS INC·Filed 2005·Granted Dec 14, 2010·13 cites·17 claims
- 0279US2025248996A1Protein kinase c inhibitors for treatment of uveal melanomaNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0378US11413284B2Protein kinase C inhibitors for treatment of uveal melanomaNOVARTIS AG·Filed 2018·Granted Aug 16, 2022·2 cites·16 claims
- 0476US12208097B2Protein kinase C inhibitors for treatment of uveal melanomaNOVARTIS AG·Filed 2022·Granted Jan 28, 2025·0 cites·16 claims
- 0565US11787813B2Substituted pyrazolopyrimidines and substituted purines and their use as ubiquitin-specific-processing protease 1 (USP1) inhibitorsKSQ THERAPEUTICS INC·Filed 2022·Granted Oct 17, 2023·0 cites·30 claims
- 0662US11485736B2Substituted pyrazolopyrimidines and substituted purines and their use as ubiquitin-specific-processing protease 1 (USP1) inhibitorsKSQ THERAPEUTICS INC·Filed 2019·Granted Nov 1, 2022·0 cites·45 claims
- 0759US2025213574A1Therapeutic combinations comprising ubiquitin- specific-processing protease 1 (usp1) inhibitors and chemotherapy agentsKSQ THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0857US2025161306A1Ubiquitin-specific-processing protease 1 (usp1) inhibitors for the treatment of solid tumorsKSQ THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0951US2023277533A1Therapeutic combinations comprising ubiquitin-specific-processing protease 1 (usp1) inhibitors and poly (adp-ribose) polymerase (parp) inhibitorsKSQ THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Alistair Wylie files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →